A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease
Public ClinicalTrials.gov record NCT00134264. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 3 Multi Center, Double Blind, Randomized, Parallel Group Evaluation Of The Fixed Combination Torcetrapib/Atorvastatin, Administered Orally, Once Daily (Qd), Compared With Atorvastatin Alone, On The Occurrence Of Major Cardiovascular Events In Subjects With Coronary Heart Disease Or Risk Equivalents
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Torcetrapib project was terminated on December 2, 2006 due to safety findings. To demonstrate if torcetrapib/atorvastatin can reduce the risk for major cardiovascular disease events, when compared to atorvastatin alone, in patients with coronary heart disease or risk equivalents
Study identification
- NCT ID
- NCT00134264
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 15,067 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 45 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2004 (Type not available)
- Primary completion
- Jun 2007 (Actual)
- Completion
- Jun 2007 (Actual)
- Last update posted
- Feb 3, 2012
2004 – 2007
United States locations
- U.S. sites
- 95
- U.S. states
- 37
- U.S. cities
- 95
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Alabaster | Alabama | — | — |
| Pfizer Investigational Site | Birmingham | Alabama | — | — |
| Pfizer Investigational Site | Gilbert | Arizona | — | — |
| Pfizer Investigational Site | Phoenix | Arizona | — | — |
| Pfizer Investigational Site | Tucson | Arizona | — | — |
| Pfizer Investigational Site | Fresno | California | — | — |
| Pfizer Investigational Site | Los Angeles | California | — | — |
| Pfizer Investigational Site | Modesto | California | — | — |
| Pfizer Investigational Site | San Diego | California | — | — |
| Pfizer Investigational Site | Santa Rosa | California | — | — |
| Pfizer Investigational Site | Tustin | California | — | — |
| Pfizer Investigational Site | Walnut Creek | California | — | — |
| Pfizer Investigational Site | Denver | Colorado | — | — |
| Pfizer Investigational Site | Longmont | Colorado | — | — |
| Pfizer Investigational Site | Guilford | Connecticut | — | — |
| Pfizer Investigational Site | Hartford | Connecticut | — | — |
| Pfizer Investigational Site | Washington D.C. | District of Columbia | — | — |
| Pfizer Investigational Site | Clearwater | Florida | — | — |
| Pfizer Investigational Site | Coral Gables | Florida | — | — |
| Pfizer Investigational Site | Fort Meyers | Florida | — | — |
| Pfizer Investigational Site | Jacksonville | Florida | — | — |
| Pfizer Investigational Site | Jacksonville Beach | Florida | — | — |
| Pfizer Investigational Site | Lakeland | Florida | — | — |
| Pfizer Investigational Site | Orlando | Florida | — | — |
| Pfizer Investigational Site | Pensacola | Florida | — | — |
| Pfizer Investigational Site | Port Charlotte | Florida | — | — |
| Pfizer Investigational Site | Sarasota | Florida | — | — |
| Pfizer Investigational Site | West Palm Beach | Florida | — | — |
| Pfizer Investigational Site | Atlanta | Georgia | — | — |
| Pfizer Investigational Site | Aurora | Illinois | — | — |
| Pfizer Investigational Site | Blue Island | Illinois | — | — |
| Pfizer Investigational Site | Chicago | Illinois | — | — |
| Pfizer Investigational Site | Evansville | Indiana | — | — |
| Pfizer Investigational Site | Fort Wayne | Indiana | — | — |
| Pfizer Investigational Site | Davenport | Iowa | — | — |
| Pfizer Investigational Site | Des Moines | Iowa | — | — |
| Pfizer Investigational Site | Iowa City | Iowa | — | — |
| Pfizer Investigational Site | Wichita | Kansas | — | — |
| Pfizer Investigational Site | Witchita | Kansas | — | — |
| Pfizer Investigational Site | Louisville | Kentucky | — | — |
| Pfizer Investigational Site | Baton Rouge | Louisiana | — | — |
| Pfizer Investigational Site | Covington | Louisiana | — | — |
| Pfizer Investigational Site | Marrero | Louisiana | — | — |
| Pfizer Investigational Site | Scarborough | Maine | — | — |
| Pfizer Investigational Site | Baltimore | Maryland | — | — |
| Pfizer Investigational Site | Bel Air | Maryland | — | — |
| Pfizer Investigational Site | Columbia | Maryland | — | — |
| Pfizer Investigational Site | Towson | Maryland | — | — |
| Pfizer Investigational Site | Westminster | Maryland | — | — |
| Pfizer Investigational Site | Abington | Massachusetts | — | — |
| Pfizer Investigational Site | Haverhill | Massachusetts | — | — |
| Pfizer Investigational Site | Natick | Massachusetts | — | — |
| Pfizer Investigational Site | Grand Rapids | Michigan | — | — |
| Pfizer Investigational Site | Minneapolis | Minnesota | — | — |
| Pfizer Investigational Site | Saint Paul | Minnesota | — | — |
| Pfizer Investigational Site | St Louis | Missouri | — | — |
| Pfizer Investigational Site | Billings | Montana | — | — |
| Pfizer Investigational Site | Butte | Montana | — | — |
| Pfizer Investigational Site | Omaha | Nebraska | — | — |
| Pfizer Investigational Site | Papillon | Nebraska | — | — |
| Pfizer Investigational Site | Las Vegas | Nevada | — | — |
| Pfizer Investigational Site | Concord | New Hampshire | — | — |
| Pfizer Investigational Site | Lebanon | New Hampshire | — | — |
| Pfizer Investigational Site | Manchester | New Hampshire | — | — |
| Pfizer Investigational Site | Elmer | New Jersey | — | — |
| Pfizer Investigational Site | Haddon Heights | New Jersey | — | — |
| Pfizer Investigational Site | New Brunswick | New Jersey | — | — |
| Pfizer Investigational Site | Garden City | New York | — | — |
| Pfizer Investigational Site | New Hyde Park | New York | — | — |
| Pfizer Investigational Site | Rochester | New York | — | — |
| Pfizer Investigational Site | Durham | North Carolina | — | — |
| Pfizer Investigational Site | Winston-Salem | North Carolina | — | — |
| Pfizer Investigational Site | Cincinnati | Ohio | — | — |
| Pfizer Investigational Site | Cleveland | Ohio | — | — |
| Pfizer Investigational Site | Columbus | Ohio | — | — |
| Pfizer Investigational Site | Mansfield | Ohio | — | — |
| Pfizer Investigational Site | Sandusky | Ohio | — | — |
| Pfizer Investigational Site | Toledo | Ohio | — | — |
| Pfizer Investigational Site | Oklahoma City | Oklahoma | — | — |
| Pfizer Investigational Site | Portland | Oregon | — | — |
| Pfizer Investigational Site | Beaver | Pennsylvania | — | — |
| Pfizer Investigational Site | Philadelphia | Pennsylvania | — | — |
| Pfizer Investigational Site | Kingsport | Tennessee | — | — |
| Pfizer Investigational Site | Nashville | Tennessee | — | — |
| Pfizer Investigational Site | Beaumont | Texas | — | — |
| Pfizer Investigational Site | Dallas | Texas | — | — |
| Pfizer Investigational Site | Houston | Texas | — | — |
| Pfizer Investigational Site | Plano | Texas | — | — |
| Pfizer Investigational Site | San Antonio | Texas | — | — |
| Pfizer Investigational Site | Salt Lake City | Utah | — | — |
| Pfizer Investigational Site | Burlington | Vermont | — | — |
| Pfizer Investigational Site | Norfolk | Virginia | — | — |
| Pfizer Investigational Site | Richmond | Virginia | — | — |
| Pfizer Investigational Site | Burien | Washington | — | — |
| Pfizer Investigational Site | Tacoma | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 126 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00134264, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 3, 2012 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00134264 live on ClinicalTrials.gov.